COVID lockdown pushers and pandemic-hysteria-embracing “journalists” are hoping that we forget the disastrous policies and vaccine mandates that were rolled out under the banners of “science” and “public health.” I guarantee that will not happen.
For months in 2021, much of the press echoed health authorities in stating there was “no link” between covid vaccines and reports of dangerous blood clots, often framing early concerns as misinformation or lacking any proven causal connection. Headlines cited regulators and experts who said vaccines “do not induce blood clots” and that there was “no link” between the AstraZeneca shot and clotting disorders, even as several countries paused rollouts to investigate unusual cases.
It’s important to note vaccines have not been shown to cause blood clots, according to Dr. Daniel Salmon of Johns Hopkins’ Institute for Vaccine Safety to the New York Times in March.”There are a lot of causes of blood clotting, a lot of predisposing factors, and a lot of people who are at increased risk – and these are often also the people who are being vaccinated right now,” said Dr. Mark Slifka, a vaccine researcher at Oregon Health and Science University, also to the Times.
Only later did agencies such as the European Medicines Agency acknowledge a “possible link” between adenovirus-based vaccines and a new syndrome, now called vaccine-induced immune thrombocytopenia and thrombosis (VITT).
The European Medicines Agency said a very rare side effect of the AstraZeneca COVID-19 vaccine is “unusual blood clots with low blood platelets.” That’s a blow to low- and middle-income countries because the vaccine is inexpensive, easier to transport and store and is also 79 percent effective at preventing infections.
Now scientists have determined the reasons clots can appear… and have the freedom to publish and share their results in both the press and on social media.
To begin this explanation, it is important to note that the human body normally produces defenses (antibodies) that recognize a protein in the blood called platelet factor 4, which is usually harmless. But in VITT, the antibodies that form are extra “sticky,” so they bind to platelet factor 4 very tightly and in large numbers. These big clumps of antibodies and proteins (called immune complexes) can then trigger the blood to clot in dangerous ways.
Why? It appears that individual factors in antibodies may make them more prone to such clotting. These antibody factors make it more likely for clots to develop.
Now an international team of scientists in Australia, Canada, and Germany has provided an answer. In an elegant set of experiments, they showed that virtually all patients with VITT share a distinctive pattern in their antibodies.They studied 100 patients with VITT from around the world. By chance, two of these patients had donated blood in the past, meaning samples were taken before vaccination and stored in German blood service freezers. These samples turned out to be the key that unlocked the mystery.The team was able to show that the antibodies involved in VITT begin as antibodies that recognise an adenoviral protein called protein VII. These antibodies probably came from the immune system’s memory of earlier adenovirus infections, which are common in childhood and cause mild cold-like symptoms.During normal immune responses to infection and vaccination, tiny random genetic changes occur in cells that produce antibodies. This is normal, and these changes help the immune system refine antibodies so they fight infections more effectively.
The AstraZeneca covid vaccine uses an adenovirus as its “delivery vehicle,” which is why the two are connected.
In fact, in 2024, I noted that AstraZeneca was forced to admit in court that its vaccine could cause blood clots.
AstraZeneca is contesting the claims but has accepted, in a legal document submitted to the High Court in February, that its Covid vaccine “can, in very rare cases, cause TTS”.…Fifty-one cases have been lodged in the High Court, with victims and grieving relatives seeking damages estimated to be worth up to £100 million.
In the end, the tragedy of VITT is not only that a rare and serious side effect occurred, but that it took so long for honest discussion and rigorous science to be allowed into the open.
The same authorities and media outlets that once dismissed any potential link between adenovirus‑based vaccines and unusual clotting as “misinformation” are now going to have to acknowledge that some vaccines can trigger a distinct immune reaction that leads to dangerous blood clots.
That shift did not come from censorship, slogans, or mandates; it came from careful clinicians, laboratory scientists, and injured patients who insisted on asking hard questions until the mechanism was finally understood.
If there is any lesson to carry forward, it is that effective public health policy depends on transparency and a willingness to follow the evidence… even when it complicates the preferred narrative… so that future crises are met with both scientific rigor and respect for the people most affected.
CLICK HERE FOR FULL VERSION OF THIS STORY